Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.0049 0.9
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0033 0.9
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0031 0.9
mRNA Imatinib GDSC1000 pan-cancer AAC -0.0045 0.9
mRNA Bortezomib gCSI pan-cancer AAC 0.0049 0.9
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.0028 0.9
mRNA KIN001-102 GDSC1000 pan-cancer AAC -0.0023 0.9
mRNA A-804598 CTRPv2 pan-cancer AAC -0.0036 0.9
mRNA prima-1 CTRPv2 pan-cancer AAC 0.0024 0.9
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.0024 0.9
Download CSV